Ontario Genomics [formerly “Ontario Genomics Institute” (OGI)] announced the appointment of Ihor P. Boszko as Vice President, Business Development.
In his mandate, Mr. Boszko will lead and manage all aspects of business development in diverse sectors including human health, agriculture, mining, water and forestry.
“We are delighted to have Ihor on our team,” said Dr. Mark Poznansky, President & CEO of Ontario Genomics. “Ihor is a transformational leader, and I’m confident that he will build on his achievements in commercializing health innovations, to help our organization solve broader industry challenges”.
In his progressive career, Mr. Boszko has been developing, commercializing and partnering innovative technologies in the medical diagnostics industry for nearly 15 years. Most recently, in his role as Vice President, Business Development of Xagenic Inc., Mr. Boszko led the company’s global commercialization plan for a breakthrough molecular diagnostics platform.
“Ontario Genomics has successfully worked with companies across many commercial sectors to enable funding and development of early stage, industry-relevant genomic technologies, with the goal of bringing to market innovative solutions for unmet needs,” said Ihor Boszko. “I am pleased to join the talented team at Ontario Genomics to lead the business development programs geared towards funding and supporting promising innovations.”
His expertise in identifying and developing commercially-relevant technologies, as well as partnering with leaders in the life sciences industry, will be tremendous assets in this new role, which he started on October 3, 2016.
